뉴욕의 겸형 적혈구증 임상 시험
겸형 적혈구증 관련 연구 21개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens Hospital at Montefiore, The Bronx
피험자 모집 중3상
12세 ~ 100세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Mount Sinai Hospital, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
피험자 모집 중3상
2세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- NYC Health+Hospitals, Brooklyn
- Interfaith Medical Center, Brooklyn
- Cohen Children's Medical Ctr, Queens
- 외 2개
피험자 모집 중3상
12세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Icahn School of Medicine at Mount Sinai, New York
- Jacobi Medical Center, The Bronx
피험자 모집 중2/3상
12세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- 외 2개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Mount Sinai Medical Center, New York
- Jacobi Medical Center, The Bronx
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Jacobi Medical Center, The Bronx
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Richmond University Medical Center- Site Number : 8400038, Staten Island
- Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx
피험자 모집 중3상
10세 ~ 65세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- New York Medical College, Valhalla
피험자 모집 중2상
6 Months – 21 Years · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT02675959Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
피험자 모집 중1/2상
12세 ~ 50세 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT04819841131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
- Columbia University Irving Medical Center, New York
피험자 모집 중1상
12세 ~ 50세 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT07015684Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Roswell Park (MRD-HCT), Buffalo
- Columbia Presbytarian (NT-DMT), New York
- Cohen's Children Hospital (NT-DMT), Queens
- 외 4개
피험자 모집 중관찰 연구
3세 ~ 20세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT06941389A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
피험자 모집 중2상
2세 ~ 50세 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
피험자 모집 중3상
12세 ~ 35세 · 모든 성별 · 2026. 3. 23. 업데이트됨 · NCT05477563Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Columbia University, New York
피험자 모집 중2상
2세 ~ 25세 · 모든 성별 · 2026. 3. 10. 업데이트됨 · NCT03587272A Long-term Follow-up Study in Patients Who Received BEAM-101
- Columbia University Irving Medical Center, New York
피험자 모집 중관찰 연구
14세 ~ 37세 · 모든 성별 · 2026. 1. 28. 업데이트됨 · NCT07373639Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Weil Cornell Medical College, New York
- University of Rochester Medical Center, Rochester
피험자 모집 중
16세 ~ 30세 · 모든 성별 · 2026. 1. 7. 업데이트됨 · NCT06374238Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
- Mount Sinai Hospital, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 10. 2. 업데이트됨 · NCT05519111AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
피험자 모집 중2상
1 Day – 30 Years · 모든 성별 · 2025. 8. 8. 업데이트됨 · NCT04099966Cannabidiol in Sickle Cell Disease
- Icahn School of Medicine at Mount Sinai, Manhattan
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 6. 25. 업데이트됨 · NCT06930703ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.